Project
Illumina Body Map 2
Navigation
Downloads
Results for ZNF740_ZNF219
Z-value: 1.66
Motif logo
Transcription factors associated with ZNF740_ZNF219
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF740
|
ENSG00000139651.9 | zinc finger protein 740 |
|
ZNF219
|
ENSG00000165804.11 | zinc finger protein 219 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF219 | hg19_v2_chr14_-_21562671_21562702 | -0.45 | 1.1e-02 | Click! |
| ZNF740 | hg19_v2_chr12_+_53574464_53574539 | -0.04 | 8.1e-01 | Click! |
Activity profile of ZNF740_ZNF219 motif
Sorted Z-values of ZNF740_ZNF219 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr6_-_32157947 | 7.42 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
| chr20_-_22565101 | 5.63 |
ENST00000419308.2
|
FOXA2
|
forkhead box A2 |
| chr11_-_46142948 | 4.63 |
ENST00000257821.4
|
PHF21A
|
PHD finger protein 21A |
| chr16_+_30675654 | 4.46 |
ENST00000287468.5
ENST00000395073.2 |
FBRS
|
fibrosin |
| chr18_+_3449821 | 4.14 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr9_-_20622478 | 4.08 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
| chr11_-_46142615 | 4.07 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr6_+_149638876 | 3.83 |
ENST00000392282.1
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
| chr2_-_148779106 | 3.65 |
ENST00000416719.1
ENST00000264169.2 |
ORC4
|
origin recognition complex, subunit 4 |
| chr11_-_46142505 | 3.56 |
ENST00000524497.1
ENST00000418153.2 |
PHF21A
|
PHD finger protein 21A |
| chr8_+_95653302 | 3.54 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr18_+_3449695 | 3.44 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr1_+_43148625 | 3.41 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
| chr8_+_95653373 | 3.38 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr12_-_57522813 | 3.15 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
| chr20_-_52210368 | 3.13 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
| chr12_+_54378849 | 3.13 |
ENST00000515593.1
|
HOXC10
|
homeobox C10 |
| chr8_+_95653427 | 3.10 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr5_+_137688285 | 3.08 |
ENST00000314358.5
|
KDM3B
|
lysine (K)-specific demethylase 3B |
| chr17_+_55333876 | 2.89 |
ENST00000284073.2
|
MSI2
|
musashi RNA-binding protein 2 |
| chr2_+_5832799 | 2.87 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
| chr12_+_57853918 | 2.73 |
ENST00000532291.1
ENST00000543426.1 ENST00000228682.2 ENST00000546141.1 |
GLI1
|
GLI family zinc finger 1 |
| chr12_+_53774423 | 2.68 |
ENST00000426431.2
|
SP1
|
Sp1 transcription factor |
| chr17_+_42634844 | 2.67 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr3_+_184032919 | 2.65 |
ENST00000427845.1
ENST00000342981.4 ENST00000319274.6 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
| chr15_-_61521495 | 2.63 |
ENST00000335670.6
|
RORA
|
RAR-related orphan receptor A |
| chr15_-_41408409 | 2.63 |
ENST00000361937.3
|
INO80
|
INO80 complex subunit |
| chr18_+_3450161 | 2.56 |
ENST00000551402.1
ENST00000577543.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr12_-_6715808 | 2.56 |
ENST00000545584.1
|
CHD4
|
chromodomain helicase DNA binding protein 4 |
| chr13_-_52027134 | 2.51 |
ENST00000311234.4
ENST00000425000.1 ENST00000463928.1 ENST00000442263.3 ENST00000398119.2 |
INTS6
|
integrator complex subunit 6 |
| chr17_+_36861735 | 2.48 |
ENST00000378137.5
ENST00000325718.7 |
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 |
| chr3_-_113415441 | 2.45 |
ENST00000491165.1
ENST00000316407.4 |
KIAA2018
|
KIAA2018 |
| chr3_-_171178157 | 2.42 |
ENST00000465393.1
ENST00000436636.2 ENST00000369326.5 ENST00000538048.1 ENST00000341852.6 |
TNIK
|
TRAF2 and NCK interacting kinase |
| chr16_+_29817841 | 2.40 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr2_+_149402553 | 2.39 |
ENST00000258484.6
ENST00000409654.1 |
EPC2
|
enhancer of polycomb homolog 2 (Drosophila) |
| chr12_+_53845879 | 2.32 |
ENST00000359282.5
ENST00000603815.1 ENST00000447282.1 ENST00000437231.1 ENST00000549863.1 ENST00000359462.5 ENST00000550520.2 ENST00000546463.1 ENST00000552296.2 |
PCBP2
|
poly(rC) binding protein 2 |
| chr5_+_133861339 | 2.31 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
| chr17_+_55334364 | 2.30 |
ENST00000322684.3
ENST00000579590.1 |
MSI2
|
musashi RNA-binding protein 2 |
| chr19_-_36233332 | 2.26 |
ENST00000592537.1
ENST00000246532.1 ENST00000344990.3 ENST00000588992.1 |
IGFLR1
|
IGF-like family receptor 1 |
| chr17_-_7141490 | 2.20 |
ENST00000574236.1
ENST00000572789.1 |
PHF23
|
PHD finger protein 23 |
| chr6_+_31865552 | 2.19 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
| chr7_+_21467642 | 2.18 |
ENST00000222584.3
ENST00000432066.2 |
SP4
|
Sp4 transcription factor |
| chr17_+_7788104 | 2.17 |
ENST00000380358.4
|
CHD3
|
chromodomain helicase DNA binding protein 3 |
| chr1_+_154975110 | 2.14 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
| chr17_-_46703826 | 2.14 |
ENST00000550387.1
ENST00000311177.5 |
HOXB9
|
homeobox B9 |
| chr17_-_46692457 | 2.13 |
ENST00000468443.1
|
HOXB8
|
homeobox B8 |
| chr2_-_174828892 | 2.12 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
| chr3_+_184033551 | 2.07 |
ENST00000456033.1
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
| chr6_-_34664612 | 2.05 |
ENST00000374023.3
ENST00000374026.3 |
C6orf106
|
chromosome 6 open reading frame 106 |
| chr17_+_43239191 | 2.01 |
ENST00000589230.1
|
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
| chr10_-_13390021 | 1.99 |
ENST00000537130.1
|
SEPHS1
|
selenophosphate synthetase 1 |
| chr3_-_88108212 | 1.99 |
ENST00000482016.1
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
| chr3_+_107243204 | 1.98 |
ENST00000456817.1
ENST00000458458.1 |
BBX
|
bobby sox homolog (Drosophila) |
| chr19_-_40324255 | 1.97 |
ENST00000593685.1
ENST00000600611.1 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr2_-_61697862 | 1.96 |
ENST00000398571.2
|
USP34
|
ubiquitin specific peptidase 34 |
| chr19_+_50094866 | 1.96 |
ENST00000418929.2
|
PRR12
|
proline rich 12 |
| chr12_+_57522692 | 1.96 |
ENST00000554174.1
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr3_+_184033135 | 1.95 |
ENST00000424196.1
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
| chr3_-_88108192 | 1.95 |
ENST00000309534.6
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
| chr6_-_151712673 | 1.91 |
ENST00000325144.4
|
ZBTB2
|
zinc finger and BTB domain containing 2 |
| chr10_+_114709999 | 1.90 |
ENST00000355995.4
ENST00000545257.1 ENST00000543371.1 ENST00000536810.1 ENST00000355717.4 ENST00000538897.1 ENST00000534894.1 |
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box) |
| chr2_-_61765315 | 1.89 |
ENST00000406957.1
ENST00000401558.2 |
XPO1
|
exportin 1 (CRM1 homolog, yeast) |
| chr17_-_58469474 | 1.88 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
| chr3_-_171177852 | 1.88 |
ENST00000284483.8
ENST00000475336.1 ENST00000357327.5 ENST00000460047.1 ENST00000488470.1 ENST00000470834.1 |
TNIK
|
TRAF2 and NCK interacting kinase |
| chr20_+_57466461 | 1.88 |
ENST00000306090.10
|
GNAS
|
GNAS complex locus |
| chr17_+_43238438 | 1.88 |
ENST00000593138.1
ENST00000586681.1 |
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
| chr16_+_30709530 | 1.87 |
ENST00000411466.2
|
SRCAP
|
Snf2-related CREBBP activator protein |
| chr1_+_43148059 | 1.86 |
ENST00000321358.7
ENST00000332220.6 |
YBX1
|
Y box binding protein 1 |
| chr2_-_208030647 | 1.84 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
| chr2_-_145277882 | 1.84 |
ENST00000465070.1
ENST00000444559.1 |
ZEB2
|
zinc finger E-box binding homeobox 2 |
| chr9_-_127269661 | 1.83 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
| chr4_+_154387480 | 1.82 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
| chr1_-_204121298 | 1.81 |
ENST00000367199.2
|
ETNK2
|
ethanolamine kinase 2 |
| chr12_+_54378923 | 1.81 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
| chr12_+_53817633 | 1.79 |
ENST00000257863.4
ENST00000550311.1 ENST00000379791.3 |
AMHR2
|
anti-Mullerian hormone receptor, type II |
| chr1_-_150208498 | 1.78 |
ENST00000314136.8
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
| chr17_-_36105009 | 1.77 |
ENST00000560016.1
ENST00000427275.2 ENST00000561193.1 |
HNF1B
|
HNF1 homeobox B |
| chr15_-_56535464 | 1.77 |
ENST00000559447.2
ENST00000422057.1 ENST00000317318.6 ENST00000423270.1 |
RFX7
|
regulatory factor X, 7 |
| chr1_+_212458834 | 1.77 |
ENST00000261461.2
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha |
| chr13_-_52026730 | 1.77 |
ENST00000420668.2
|
INTS6
|
integrator complex subunit 6 |
| chr3_+_154797877 | 1.75 |
ENST00000462745.1
ENST00000493237.1 |
MME
|
membrane metallo-endopeptidase |
| chr6_+_42749759 | 1.74 |
ENST00000314073.5
|
GLTSCR1L
|
GLTSCR1-like |
| chr15_-_41408339 | 1.74 |
ENST00000401393.3
|
INO80
|
INO80 complex subunit |
| chr1_-_204121102 | 1.72 |
ENST00000367202.4
|
ETNK2
|
ethanolamine kinase 2 |
| chr10_+_21823079 | 1.71 |
ENST00000377100.3
ENST00000377072.3 ENST00000446906.2 |
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
| chr8_-_57123815 | 1.69 |
ENST00000316981.3
ENST00000423799.2 ENST00000429357.2 |
PLAG1
|
pleiomorphic adenoma gene 1 |
| chr2_+_219264466 | 1.69 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr12_+_53773944 | 1.68 |
ENST00000551969.1
ENST00000327443.4 |
SP1
|
Sp1 transcription factor |
| chr2_+_111878483 | 1.67 |
ENST00000308659.8
ENST00000357757.2 ENST00000393253.2 ENST00000337565.5 ENST00000393256.3 |
BCL2L11
|
BCL2-like 11 (apoptosis facilitator) |
| chr12_+_53846594 | 1.66 |
ENST00000550192.1
|
PCBP2
|
poly(rC) binding protein 2 |
| chr8_-_101734170 | 1.66 |
ENST00000522387.1
ENST00000518196.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr17_-_42297092 | 1.65 |
ENST00000393606.3
|
UBTF
|
upstream binding transcription factor, RNA polymerase I |
| chr6_+_45390222 | 1.65 |
ENST00000359524.5
|
RUNX2
|
runt-related transcription factor 2 |
| chr19_+_35759824 | 1.65 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
| chr7_-_27142290 | 1.65 |
ENST00000222718.5
|
HOXA2
|
homeobox A2 |
| chr12_+_53818855 | 1.64 |
ENST00000550839.1
|
AMHR2
|
anti-Mullerian hormone receptor, type II |
| chr1_-_27930102 | 1.64 |
ENST00000247087.5
ENST00000374011.2 |
AHDC1
|
AT hook, DNA binding motif, containing 1 |
| chr2_-_161349909 | 1.63 |
ENST00000392753.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
| chr2_+_181845532 | 1.62 |
ENST00000602475.1
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
| chr1_+_26737292 | 1.61 |
ENST00000254231.4
|
LIN28A
|
lin-28 homolog A (C. elegans) |
| chr18_+_55102917 | 1.57 |
ENST00000491143.2
|
ONECUT2
|
one cut homeobox 2 |
| chr5_+_36876833 | 1.57 |
ENST00000282516.8
ENST00000448238.2 |
NIPBL
|
Nipped-B homolog (Drosophila) |
| chr12_+_122064673 | 1.57 |
ENST00000537188.1
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1 |
| chr2_+_181845763 | 1.54 |
ENST00000602499.1
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
| chr1_-_111746966 | 1.53 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
| chr17_+_38497640 | 1.52 |
ENST00000394086.3
|
RARA
|
retinoic acid receptor, alpha |
| chr3_+_154797636 | 1.50 |
ENST00000481828.1
|
MME
|
membrane metallo-endopeptidase |
| chr7_+_106809406 | 1.47 |
ENST00000468410.1
ENST00000478930.1 ENST00000464009.1 ENST00000222574.4 |
HBP1
|
HMG-box transcription factor 1 |
| chr6_+_37787704 | 1.47 |
ENST00000474522.1
|
ZFAND3
|
zinc finger, AN1-type domain 3 |
| chr19_-_14201776 | 1.45 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr2_+_181845843 | 1.45 |
ENST00000602710.1
|
UBE2E3
|
ubiquitin-conjugating enzyme E2E 3 |
| chr17_+_37618257 | 1.44 |
ENST00000447079.4
|
CDK12
|
cyclin-dependent kinase 12 |
| chr16_-_4323015 | 1.44 |
ENST00000204517.6
|
TFAP4
|
transcription factor AP-4 (activating enhancer binding protein 4) |
| chr19_+_45754505 | 1.44 |
ENST00000262891.4
ENST00000300843.4 |
MARK4
|
MAP/microtubule affinity-regulating kinase 4 |
| chr3_-_18466026 | 1.44 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
| chr7_+_100318423 | 1.43 |
ENST00000252723.2
|
EPO
|
erythropoietin |
| chr1_-_53019059 | 1.43 |
ENST00000484723.2
ENST00000524582.1 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
| chr7_-_127672146 | 1.42 |
ENST00000476782.1
|
LRRC4
|
leucine rich repeat containing 4 |
| chr1_-_204121013 | 1.42 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
| chr5_-_142784101 | 1.42 |
ENST00000503201.1
ENST00000502892.1 |
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| chr1_-_53018654 | 1.41 |
ENST00000257177.4
ENST00000355809.4 ENST00000528642.1 ENST00000470626.1 ENST00000371544.3 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
| chr6_-_44095183 | 1.40 |
ENST00000372014.3
|
MRPL14
|
mitochondrial ribosomal protein L14 |
| chr12_-_54813229 | 1.40 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr17_+_36858694 | 1.39 |
ENST00000563897.1
|
CTB-58E17.1
|
CTB-58E17.1 |
| chr1_-_151431674 | 1.39 |
ENST00000531094.1
|
POGZ
|
pogo transposable element with ZNF domain |
| chr1_+_27022485 | 1.39 |
ENST00000324856.7
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
| chr10_+_21823243 | 1.39 |
ENST00000307729.7
ENST00000377091.2 |
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
| chr17_-_27277615 | 1.36 |
ENST00000583747.1
ENST00000584236.1 |
PHF12
|
PHD finger protein 12 |
| chr1_+_147013182 | 1.35 |
ENST00000234739.3
|
BCL9
|
B-cell CLL/lymphoma 9 |
| chr17_+_1646130 | 1.34 |
ENST00000453066.1
ENST00000324015.3 ENST00000450523.2 ENST00000453723.1 ENST00000382061.4 |
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
| chr17_+_46132037 | 1.33 |
ENST00000582155.1
ENST00000583378.1 ENST00000536222.1 |
NFE2L1
|
nuclear factor, erythroid 2-like 1 |
| chr20_+_57466357 | 1.33 |
ENST00000371095.3
ENST00000371085.3 ENST00000354359.7 ENST00000265620.7 |
GNAS
|
GNAS complex locus |
| chr16_+_30969055 | 1.33 |
ENST00000452917.1
|
SETD1A
|
SET domain containing 1A |
| chr1_-_167906277 | 1.33 |
ENST00000271373.4
|
MPC2
|
mitochondrial pyruvate carrier 2 |
| chr1_-_21503337 | 1.32 |
ENST00000400422.1
ENST00000602326.1 ENST00000411888.1 ENST00000438975.1 |
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3 |
| chr19_-_40324767 | 1.32 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr19_+_35759968 | 1.31 |
ENST00000222305.3
ENST00000595068.1 ENST00000379134.3 ENST00000594064.1 ENST00000598058.1 |
USF2
|
upstream transcription factor 2, c-fos interacting |
| chr15_-_65477637 | 1.31 |
ENST00000300107.3
|
CLPX
|
caseinolytic mitochondrial matrix peptidase chaperone subunit |
| chr17_+_72427477 | 1.31 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr1_+_178694408 | 1.30 |
ENST00000324778.5
|
RALGPS2
|
Ral GEF with PH domain and SH3 binding motif 2 |
| chr7_-_105332084 | 1.30 |
ENST00000472195.1
|
ATXN7L1
|
ataxin 7-like 1 |
| chr11_-_67141640 | 1.29 |
ENST00000533438.1
|
CLCF1
|
cardiotrophin-like cytokine factor 1 |
| chr1_+_203765437 | 1.28 |
ENST00000550078.1
|
ZBED6
|
zinc finger, BED-type containing 6 |
| chr19_+_50433476 | 1.27 |
ENST00000596658.1
|
ATF5
|
activating transcription factor 5 |
| chr17_-_58469687 | 1.27 |
ENST00000590133.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr19_-_38916802 | 1.27 |
ENST00000587738.1
|
RASGRP4
|
RAS guanyl releasing protein 4 |
| chr1_+_27022839 | 1.27 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
| chr9_-_127269488 | 1.26 |
ENST00000455734.1
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
| chr17_-_60885645 | 1.26 |
ENST00000544856.2
|
MARCH10
|
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
| chr18_+_42260861 | 1.24 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
| chr14_-_38064198 | 1.24 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
| chr12_-_57505121 | 1.24 |
ENST00000538913.2
ENST00000537215.2 ENST00000454075.3 ENST00000554825.1 ENST00000553275.1 ENST00000300134.3 |
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
| chr19_-_14201507 | 1.23 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr15_+_101142722 | 1.22 |
ENST00000332783.7
ENST00000558747.1 ENST00000343276.4 |
ASB7
|
ankyrin repeat and SOCS box containing 7 |
| chr17_+_54671047 | 1.22 |
ENST00000332822.4
|
NOG
|
noggin |
| chr2_-_48132924 | 1.22 |
ENST00000403359.3
|
FBXO11
|
F-box protein 11 |
| chr12_-_57644952 | 1.22 |
ENST00000554578.1
ENST00000546246.2 ENST00000553489.1 ENST00000332782.2 |
STAC3
|
SH3 and cysteine rich domain 3 |
| chr17_+_43239231 | 1.21 |
ENST00000591576.1
ENST00000591070.1 ENST00000592695.1 |
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
| chrX_-_142722897 | 1.20 |
ENST00000338017.4
|
SLITRK4
|
SLIT and NTRK-like family, member 4 |
| chr2_-_220117867 | 1.20 |
ENST00000456818.1
ENST00000447205.1 |
TUBA4A
|
tubulin, alpha 4a |
| chr17_+_38278530 | 1.18 |
ENST00000398532.4
|
MSL1
|
male-specific lethal 1 homolog (Drosophila) |
| chr3_+_88108381 | 1.18 |
ENST00000473136.1
|
RP11-159G9.5
|
Uncharacterized protein |
| chr17_-_60885659 | 1.18 |
ENST00000311269.5
|
MARCH10
|
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
| chr1_-_211752073 | 1.18 |
ENST00000367001.4
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1 |
| chr1_-_151431647 | 1.17 |
ENST00000368863.2
ENST00000409503.1 ENST00000491586.1 ENST00000533351.1 ENST00000540984.1 |
POGZ
|
pogo transposable element with ZNF domain |
| chr17_-_60885700 | 1.17 |
ENST00000583600.1
|
MARCH10
|
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase |
| chrX_-_129244454 | 1.16 |
ENST00000308167.5
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
| chr3_+_5020801 | 1.15 |
ENST00000256495.3
|
BHLHE40
|
basic helix-loop-helix family, member e40 |
| chr4_+_38665810 | 1.14 |
ENST00000261438.5
ENST00000514033.1 |
KLF3
|
Kruppel-like factor 3 (basic) |
| chr12_-_6716569 | 1.14 |
ENST00000544040.1
ENST00000545942.1 |
CHD4
|
chromodomain helicase DNA binding protein 4 |
| chr6_+_31620191 | 1.14 |
ENST00000375918.2
ENST00000375920.4 |
APOM
|
apolipoprotein M |
| chr5_-_56247935 | 1.13 |
ENST00000381199.3
ENST00000381226.3 ENST00000381213.3 |
MIER3
|
mesoderm induction early response 1, family member 3 |
| chr19_-_38916822 | 1.13 |
ENST00000586305.1
|
RASGRP4
|
RAS guanyl releasing protein 4 |
| chr12_-_6716534 | 1.13 |
ENST00000544484.1
ENST00000309577.6 ENST00000357008.2 |
CHD4
|
chromodomain helicase DNA binding protein 4 |
| chr11_-_67980744 | 1.13 |
ENST00000401547.2
ENST00000453170.1 ENST00000304363.4 |
SUV420H1
|
suppressor of variegation 4-20 homolog 1 (Drosophila) |
| chr1_+_155036204 | 1.12 |
ENST00000368409.3
ENST00000359751.4 ENST00000427683.2 ENST00000556931.1 ENST00000505139.1 |
EFNA4
EFNA3
EFNA3
|
ephrin-A4 ephrin-A3 Ephrin-A3; Uncharacterized protein; cDNA FLJ57652, highly similar to Ephrin-A3 |
| chr15_+_91411810 | 1.11 |
ENST00000268171.3
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
| chr1_+_178694362 | 1.11 |
ENST00000367634.2
|
RALGPS2
|
Ral GEF with PH domain and SH3 binding motif 2 |
| chr1_+_178694300 | 1.11 |
ENST00000367635.3
|
RALGPS2
|
Ral GEF with PH domain and SH3 binding motif 2 |
| chr17_-_56065484 | 1.11 |
ENST00000581208.1
|
VEZF1
|
vascular endothelial zinc finger 1 |
| chr11_-_72493574 | 1.10 |
ENST00000536290.1
|
STARD10
|
StAR-related lipid transfer (START) domain containing 10 |
| chr3_-_53080047 | 1.10 |
ENST00000482396.1
ENST00000358080.2 ENST00000296295.6 ENST00000394752.3 |
SFMBT1
|
Scm-like with four mbt domains 1 |
| chr8_-_101734308 | 1.10 |
ENST00000519004.1
ENST00000519363.1 ENST00000520142.1 |
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr12_+_57522258 | 1.10 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr17_-_7154984 | 1.10 |
ENST00000574322.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr6_-_31763276 | 1.09 |
ENST00000440048.1
|
VARS
|
valyl-tRNA synthetase |
| chrX_-_129244655 | 1.09 |
ENST00000335997.7
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
| chr13_+_20532900 | 1.08 |
ENST00000382871.2
|
ZMYM2
|
zinc finger, MYM-type 2 |
| chr6_+_18155560 | 1.08 |
ENST00000546309.2
ENST00000388870.2 ENST00000397244.1 |
KDM1B
|
lysine (K)-specific demethylase 1B |
| chr17_+_7477040 | 1.07 |
ENST00000581384.1
ENST00000577929.1 |
EIF4A1
|
eukaryotic translation initiation factor 4A1 |
| chr1_-_149908217 | 1.06 |
ENST00000369140.3
|
MTMR11
|
myotubularin related protein 11 |
| chr1_-_150208320 | 1.06 |
ENST00000534220.1
|
ANP32E
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member E |
| chr15_-_80215984 | 1.06 |
ENST00000485386.1
ENST00000479961.1 |
ST20
ST20-MTHFS
|
suppressor of tumorigenicity 20 ST20-MTHFS readthrough |
| chr19_-_17356697 | 1.05 |
ENST00000291442.3
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6 |
| chr7_-_149470540 | 1.05 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
| chr22_+_41487711 | 1.05 |
ENST00000263253.7
|
EP300
|
E1A binding protein p300 |
| chr18_+_21594585 | 1.04 |
ENST00000317571.3
|
TTC39C
|
tetratricopeptide repeat domain 39C |
| chrX_+_123095860 | 1.04 |
ENST00000428941.1
|
STAG2
|
stromal antigen 2 |
| chr2_+_45168875 | 1.04 |
ENST00000260653.3
|
SIX3
|
SIX homeobox 3 |
| chr1_+_26856236 | 1.03 |
ENST00000374168.2
ENST00000374166.4 |
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF740_ZNF219
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 5.6 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.0 | 3.0 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 1.0 | 1.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 1.0 | 2.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.9 | 4.4 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.8 | 0.8 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.8 | 0.8 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.8 | 3.1 | GO:0060032 | notochord regression(GO:0060032) |
| 0.8 | 3.8 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.7 | 2.0 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 0.6 | 3.1 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.6 | 1.8 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.6 | 3.0 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.6 | 5.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.6 | 8.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.6 | 3.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.6 | 2.2 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.6 | 1.7 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.5 | 1.6 | GO:0035283 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.5 | 2.7 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.5 | 3.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.5 | 2.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.5 | 1.6 | GO:0061010 | external genitalia morphogenesis(GO:0035261) gall bladder development(GO:0061010) |
| 0.5 | 5.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 | 5.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.5 | 1.9 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 0.5 | 1.4 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.5 | 1.4 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.5 | 1.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.5 | 1.8 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.4 | 3.6 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 | 1.3 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.4 | 1.7 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.4 | 1.2 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.4 | 3.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.4 | 1.2 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.4 | 1.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.4 | 3.0 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.4 | 1.1 | GO:0032904 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.4 | 4.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 | 1.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.3 | 1.3 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
| 0.3 | 1.7 | GO:0070384 | growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.3 | 2.6 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.3 | 4.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 | 1.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 | 0.6 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.3 | 4.0 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 0.3 | 1.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.3 | 3.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.3 | 5.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.3 | 2.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 | 1.1 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.3 | 3.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.3 | 5.6 | GO:0007379 | segment specification(GO:0007379) |
| 0.3 | 2.7 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.3 | 2.1 | GO:0060136 | enucleate erythrocyte differentiation(GO:0043353) embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 0.5 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.3 | 2.3 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.3 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 | 1.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.3 | 0.8 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.3 | 0.8 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.2 | 1.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.2 | 0.7 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.2 | 2.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 | 1.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 0.2 | 1.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 | 0.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 | 2.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.9 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.2 | 1.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 0.7 | GO:0048627 | myoblast development(GO:0048627) |
| 0.2 | 3.1 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 2.9 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 | 3.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.2 | 2.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 | 0.9 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.2 | 1.7 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.2 | 0.6 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.2 | 1.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.2 | 2.2 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.2 | 0.8 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 3.9 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.2 | 0.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 | 1.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 | 2.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.2 | 1.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.2 | 4.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.2 | 2.2 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.2 | 0.5 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.2 | 3.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 0.9 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.2 | 0.4 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.2 | 0.5 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.2 | 1.0 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.2 | 0.7 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.2 | 1.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 0.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.2 | 6.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
| 0.2 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 1.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 5.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 1.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 | 1.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 | 0.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.6 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 4.3 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 5.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 0.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 3.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 0.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 | 1.3 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.1 | 0.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.1 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 0.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.1 | 1.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 1.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.4 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 2.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 3.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.1 | 1.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 1.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 1.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 | 0.3 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 | 0.5 | GO:0031291 | mitotic chromosome movement towards spindle pole(GO:0007079) Ran protein signal transduction(GO:0031291) |
| 0.1 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.1 | 0.9 | GO:0070885 | positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 1.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.1 | 1.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.5 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) oncogene-induced cell senescence(GO:0090402) |
| 0.1 | 2.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.4 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.1 | 0.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.1 | 0.9 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 5.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 0.5 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.4 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.1 | 0.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.1 | 1.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 4.9 | GO:0043486 | histone exchange(GO:0043486) |
| 0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 | 1.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 15.2 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.1 | 0.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 | 0.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 1.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 0.3 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.1 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 1.1 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.1 | 0.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.9 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 0.3 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.1 | 0.6 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 | 0.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 0.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 1.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 | 1.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 | 0.3 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 2.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.1 | 0.9 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 1.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 | 1.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 1.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 0.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.8 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.1 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.7 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.1 | 0.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 3.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.1 | 1.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.3 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.1 | 1.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.4 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 | 3.8 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 | 1.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.5 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.1 | 0.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 | 2.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.1 | 0.8 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 1.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.7 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 1.8 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 | 0.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 0.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 0.1 | 2.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 1.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 | 0.3 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 3.3 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 | 0.2 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.0 | 0.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.0 | 1.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.0 | 0.3 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.0 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.0 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.0 | 0.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.0 | 0.5 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 | 0.3 | GO:0019827 | stem cell population maintenance(GO:0019827) |
| 0.0 | 0.2 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.0 | 1.0 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 | 0.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.0 | 0.1 | GO:0051384 | response to glucocorticoid(GO:0051384) |
| 0.0 | 0.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.0 | 1.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.0 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.0 | 0.2 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.0 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.0 | 0.8 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.0 | 0.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 | 1.4 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 | 1.1 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 1.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.0 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 | 2.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.0 | 0.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.3 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.0 | 1.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 | 0.7 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.4 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 4.5 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.0 | 0.7 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.0 | 0.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.0 | 0.2 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.0 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.0 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.0 | 0.7 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.0 | 2.6 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 2.3 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.0 | 0.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.0 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.8 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.0 | 0.7 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 0.6 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.0 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.0 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 | 0.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 2.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.6 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.3 | GO:0032196 | transposition(GO:0032196) |
| 0.0 | 0.1 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.0 | 0.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.0 | 2.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.0 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.2 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 | 0.4 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 0.0 | 0.2 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.0 | 0.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.6 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 | 0.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.6 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 | 3.6 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 1.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 1.7 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.0 | 0.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 | 1.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.5 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.0 | 0.6 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.6 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.0 | 0.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 1.7 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 4.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.0 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 | 0.3 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
| 0.0 | 0.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.0 | 0.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.0 | 1.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.0 | 1.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.0 | 2.3 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 0.0 | 0.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.0 | 0.0 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 | 0.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.5 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.0 | 0.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 1.7 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.5 | 5.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.4 | 1.3 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.4 | 11.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.4 | 2.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.4 | 4.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.4 | 1.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.4 | 1.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.3 | 1.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.3 | 2.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.3 | 5.4 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.3 | 1.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.3 | 3.8 | GO:0072487 | MSL complex(GO:0072487) |
| 0.3 | 1.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.3 | 3.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.3 | 3.8 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 4.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.3 | 1.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.2 | 0.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 1.5 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.2 | 0.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.2 | 5.5 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.2 | 2.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 0.5 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.2 | 12.5 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.2 | 0.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.2 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
| 0.2 | 1.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 4.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 2.9 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 0.9 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 5.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 0.4 | GO:0075341 | host cell PML body(GO:0075341) |
| 0.1 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 1.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.1 | 3.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.1 | 1.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 1.2 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 3.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 3.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 9.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 6.0 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 4.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.1 | 2.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 1.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 2.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 2.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 0.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 1.1 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 4.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 3.1 | GO:0097546 | ciliary base(GO:0097546) |
| 0.1 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.0 | 8.3 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 2.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.0 | 25.7 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 1.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.0 | 0.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.8 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 5.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 2.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 5.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.0 | 1.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 0.6 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.0 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.0 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.0 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.0 | 9.4 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 22.9 | GO:0016604 | nuclear body(GO:0016604) |
| 0.0 | 0.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 1.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 0.6 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 1.4 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.0 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 87.8 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 2.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 2.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.5 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.0 | 0.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 5.1 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.7 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 0.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 1.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 2.2 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 1.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.8 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 1.0 | 3.0 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.9 | 3.4 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.6 | 4.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.5 | 1.5 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.5 | 1.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.5 | 2.8 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.5 | 1.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.5 | 1.8 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.5 | 5.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.4 | 3.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 1.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.4 | 3.3 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.4 | 9.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.4 | 1.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.3 | 1.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.3 | 1.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.3 | 8.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 2.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.3 | 2.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 10.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 2.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.3 | 0.8 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.2 | 1.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.2 | 2.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 1.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.2 | 5.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.2 | 22.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.2 | 0.9 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.2 | 1.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 8.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.2 | 2.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 1.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.2 | 1.0 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.2 | 2.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 2.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.2 | 3.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.2 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 2.6 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.2 | 2.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.2 | 3.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.2 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 3.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.2 | 1.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 0.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 1.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.6 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.1 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.1 | 8.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 2.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 1.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.1 | 0.4 | GO:0045142 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) triplex DNA binding(GO:0045142) |
| 0.1 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 7.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 0.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 0.4 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.1 | 1.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.1 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 2.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 0.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 2.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 1.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 2.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 4.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 3.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 1.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 16.5 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 3.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 1.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 0.4 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.1 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 3.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 0.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 0.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.1 | 7.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 1.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 1.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 2.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 1.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 6.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 1.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.1 | 2.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 4.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 2.0 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 1.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 53.7 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.1 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.1 | 2.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.1 | 7.2 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 3.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 11.8 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 0.4 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.1 | 1.3 | GO:0015643 | toxic substance binding(GO:0015643) proteasome binding(GO:0070628) |
| 0.1 | 0.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 1.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.0 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.0 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 0.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 4.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 5.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.0 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 1.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.0 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.0 | 1.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 1.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.0 | 0.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.0 | 2.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.5 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.0 | 0.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.1 | GO:0017153 | succinate transmembrane transporter activity(GO:0015141) sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.0 | 6.8 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 1.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.0 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
| 0.0 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.0 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.0 | 2.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 1.4 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 1.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 2.0 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.0 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.0 | 0.3 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 1.2 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) collagen V binding(GO:0070052) |
| 0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.0 | 0.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.0 | 0.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 2.0 | GO:0002020 | protease binding(GO:0002020) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 18.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 3.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 8.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 8.3 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 2.9 | PID MYC PATHWAY | C-MYC pathway |
| 0.1 | 2.3 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 6.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 2.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 14.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 11.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 13.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 3.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 1.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 3.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 10.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 1.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 3.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 3.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 3.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 3.7 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 4.9 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 0.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 5.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 2.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 3.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 3.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 2.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 2.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 1.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 2.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 2.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 1.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 1.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 2.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 1.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 0.8 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 7.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.3 | 3.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.3 | 3.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 15.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.2 | 4.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 5.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 4.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 3.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 4.6 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 6.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 2.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.1 | 10.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 3.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 2.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 2.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 5.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 2.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 2.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 1.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 1.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 3.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 2.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 0.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 2.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 4.5 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
| 0.1 | 2.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 16.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 2.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 1.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 1.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 5.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 2.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 2.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 3.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 4.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 4.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 3.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 5.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.0 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.0 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.9 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.0 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 0.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 0.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |